OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3030% below fair value
$7.31+0.37 (+5.33%)
Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –
OptimizeRx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
OptimizeRx's revenue for the twelve months ending Jun 30, 2026 was $98.65M, down 5.8% year over year. For fiscal 2025 it was $109.43M, up 18.8% from the year before. Over ten years it grew 31.2% a year on average. The highest annual figure on record is $109.43M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.43M | +18.8% |
| FY2024 | Dec 31, 2024 | $92.13M | +28.8% |
| FY2023 | Dec 31, 2023 | $71.52M | +14.5% |
| FY2022 | Dec 31, 2022 | $62.45M | +1.9% |
| FY2021 | Dec 31, 2021 | $61.29M | +41.5% |
| FY2020 | Dec 31, 2020 | $43.31M | +76.1% |
| FY2019 | Dec 31, 2019 | $24.60M | +16.0% |
| FY2018 | Dec 31, 2018 | $21.21M | +74.9% |
| FY2017 | Dec 31, 2017 | $12.13M | +56.5% |
| FY2016 | Dec 31, 2016 | $7.75M | +7.4% |
| FY2015 | Dec 31, 2015 | $7.22M | +11.0% |
| FY2014 | Dec 31, 2014 | $6.50M | +39.0% |
| FY2013 | Dec 31, 2013 | $4.68M | +135.3% |
| FY2012 | Dec 31, 2012 | $1.99M | +79.0% |
| FY2011 | Dec 31, 2011 | $1.11M | +1464.1% |
| FY2010 | Dec 31, 2010 | $71.07K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.50M | -29.8% |
| Q1 FY2026 | Mar 31, 2026 | $19.84M | -9.5% |
| Q4 FY2025 | Dec 31, 2025 | $32.24M | -0.2% |
| Q3 FY2025 | Sep 30, 2025 | $26.07M | +22.3% |
| Q2 FY2025 | Jun 30, 2025 | $29.20M | +55.2% |
| Q1 FY2025 | Mar 31, 2025 | $21.93M | +11.4% |
| Q4 FY2024 | Dec 31, 2024 | $32.32M | +13.9% |
| Q3 FY2024 | Sep 30, 2024 | $21.31M | +30.5% |
| Q2 FY2024 | Jun 30, 2024 | $18.81M | +36.1% |
| Q1 FY2024 | Mar 31, 2024 | $19.69M | +51.4% |
| Q4 FY2023 | Dec 31, 2023 | $28.37M | +44.3% |
| Q3 FY2023 | Sep 30, 2023 | $16.33M | +18.9% |
| Q2 FY2023 | Jun 30, 2023 | $13.82M | -32.0% |
| Q1 FY2023 | Mar 31, 2023 | $13.00M | -19.4% |
| Q4 FY2022 | Dec 31, 2022 | $19.65M | +44.2% |
| Q1 FY2022 | Mar 31, 2022 | $13.73M | +22.3% |
| Q4 FY2021 | Dec 31, 2021 | $20.31M | +23.7% |
| Q3 FY2021 | Sep 30, 2021 | $16.12M | +53.3% |
| Q2 FY2021 | Jun 30, 2021 | $13.63M | +55.1% |
| Q1 FY2021 | Mar 31, 2021 | $11.23M | +48.1% |
| Q4 FY2020 | Dec 31, 2020 | $16.43M | +134.5% |
| Q3 FY2020 | Sep 30, 2020 | $10.52M | +101.9% |
| Q2 FY2020 | Jun 30, 2020 | $8.78M | +33.5% |
| Q1 FY2020 | Mar 31, 2020 | $7.58M | +40.1% |
| Q2 FY2019 | Jun 30, 2019 | $7.01M | +37.4% |
| Q1 FY2019 | Mar 31, 2019 | $5.21M | +26.7% |
| Q4 FY2018 | Dec 31, 2018 | $6.58M | +64.2% |
| Q3 FY2018 | Sep 30, 2018 | $5.42M | +74.5% |
| Q2 FY2018 | Jun 30, 2018 | $5.10M | +77.9% |
| Q1 FY2018 | Mar 31, 2018 | $4.11M | +91.1% |
| Q4 FY2017 | Dec 31, 2017 | $4.01M | +74.8% |
| Q3 FY2017 | Sep 30, 2017 | $3.10M | +73.7% |
| Q2 FY2017 | Jun 30, 2017 | $2.87M | +49.8% |
| Q1 FY2017 | Mar 31, 2017 | $2.15M | +22.3% |
| Q4 FY2016 | Dec 31, 2016 | $2.29M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.79M | – |
| Q2 FY2016 | Jun 30, 2016 | $1.91M | – |
| Q1 FY2016 | Mar 31, 2016 | $1.76M | – |
See a number that looks wrong?